AssetMark Inc’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-72
Closed -$650 3086
2025
Q1
$650 Hold
72
﹤0.01% 2363
2024
Q4
$941 Buy
72
+12
+20% +$160 ﹤0.01% 2255
2024
Q3
$941 Sell
60
-298
-83% -$4.51K ﹤0.01% 2011
2024
Q2
$4.83K Buy
358
+179
+100% +$3.67K ﹤0.01% 1605
2024
Q1
$4.96K Sell
179
-147
-45% -$3.26K ﹤0.01% 1465
2023
Q4
$6.28K Buy
326
+62
+23% +$1.12K ﹤0.01% 1428
2023
Q3
$4.27K Sell
264
-43
-14% -$763 ﹤0.01% 1405
2023
Q2
$5.84K Sell
307
-11
-3% -$196 ﹤0.01% 1337
2023
Q1
$4.63K Buy
318
+107
+51% +$1.92K ﹤0.01% 1336
2022
Q4
$4.12K Buy
211
+9
+4% +$176 ﹤0.01% 1375
2022
Q3
$5K Buy
202
+3
+2% +$92 ﹤0.01% 1303
2022
Q2
$6K Buy
199
+93
+88% +$3.37K ﹤0.01% 1282
2022
Q1
$5K Sell
106
-1
-0.9% -$43 ﹤0.01% 1281
2021
Q4
$5K Sell
107
-5
-4% -$196 ﹤0.01% 1241
2021
Q3
$4K Hold
112
﹤0.01% 1183
2021
Q2
$5K Buy
+112
New +$4.36K ﹤0.01% 1080
2018
Q1
Sell
-13
Closed 1816
2017
Q4
$0 Buy
+13
New +$288 ﹤0.01% 2053
2017
Q1
Sell
-7
Closed 1386
2016
Q4
$0 Buy
+7
New +$237 ﹤0.01% 1344

Other funds holding ACH

AssetMark Inc's ACH Position: Q2 2025 in Review

AssetMark Inc sold out of Accendra Health (ACH) in Q2 2025, closing a stake of 72 shares — an estimated $650 sold.

AssetMark Inc first reported a position in ACH in Q4 2016 and held it in 18 quarters. The position peaked at $6.28K in Q4 2023. 234 funds tracked by Wall St. Rank hold ACH as of Q2 2025.

  • AssetMark Inc reported no remaining Accendra Health position as of Q2 2025 after selling out during the quarter.
  • AssetMark Inc sold 72 Accendra Health shares in Q2 2025, an estimated $650.
  • AssetMark Inc first reported a position in Accendra Health in Q4 2016 and held it in 18 quarters.
  • AssetMark Inc's Accendra Health position peaked at $6.28K in Q4 2023.
  • 234 funds tracked by Wall St. Rank held Accendra Health as of Q2 2025.

Based on AssetMark Inc's 13F filing for Q2 2025, filed 4 Aug 2025.